Kit formulation of Bevacizumab, an anti-VEGF monoclonal antibody, and consequent labelling with Rhenium-188: initial in vitro and in vivo studies

被引:0
|
作者
Bouziotis, P. [1 ]
Gourni, E. [1 ]
Xanthopoulos, S. [1 ]
Paravatou, M. [1 ]
Syrigos, K. [2 ]
Loudos, G. [3 ]
Archimandritis, S. C. [1 ]
Varvarigou, A. D. [1 ]
Harris, A. L. [4 ]
机构
[1] NCSR Demokritos, Inst Radioisotopes & Radiodiagnost Prod, Athens, Greece
[2] Sotiria Gen Hosp, Dept Med 3, Med Oncol Unit, Athens, Greece
[3] Technol Educ Inst Athens, Dept Med Instruments Technol, Athens, Greece
[4] Univ Oxford, Inst Mol Med, Mol Oncol Lab, Oxford, England
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S320 / S321
页数:2
相关论文
共 48 条
  • [41] Cardiac Toxicity Associated with the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin) in Combination with CROP (A-CHOP) Chemotherapy for Peripheral T Cell Lymphoma (PTCL): The ECOG 2404 Trial.
    Advani, Ranjana H.
    Hong, Fangxin
    Ganjoo, Kristen N.
    Manola, Judith B.
    Swinnen, Lode J.
    Habermann, Thomas M.
    Horning, Sandra J.
    BLOOD, 2009, 114 (22) : 667 - 667
  • [42] Synthesis of 99mTc-anti-CD56 Monoclonal Antibody for Molecular Imaging of NK Cells: in Vitro and in Vivo Studies
    Galli, F.
    Rapisarda, A.
    Stabile, H.
    Malviya, G.
    Bonanno, E.
    Gismondi, A.
    Santoni, A.
    Dierckx, R.
    Signore, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S455 - S456
  • [43] Use of a 99mTc labeled anti-TNFα monoclonal antibody in Crohn's disease:: in vitro and in vivo studies
    Dalessandria, C.
    Malviya, G.
    Viscido, A.
    Aratari, A.
    Maccioni, F.
    Amato, A.
    Scopinaro, F.
    Caprilli, R.
    Signore, A.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 51 (04): : 334 - 342
  • [44] A novel anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier system: Physical characterization and cellular uptake evaluation in vitro and in vivo
    Shi, Chenyang
    Gao, Fei
    Gao, Xiangdong
    Liu, Yu
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 69 : 191 - 200
  • [45] PREDOMINANT SUPPRESSION OF ANTI-TNP IGE RESPONSE IN MICE BY MONOCLONAL ANTI-TNP IGG1 ANTIBODY - CHARACTERIZATION OF ITS MODE OF ACTION BY IN-VITRO AND IN-VIVO STUDIES
    HASE, N
    TAKAI, T
    HIKIDA, M
    OHMORI, H
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1994, 16 (10): : 787 - 794
  • [46] Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124):: in vitro and in vivo studies
    Bolognesi, A
    Tazzari, PL
    Olivieri, F
    Polito, L
    Lemoli, R
    Terenzi, A
    Pasqualucci, L
    Falini, B
    Stirpe, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (01) : 179 - 188
  • [47] Differential lytic and agglutinating activity of the anti-Lewisx monoclonal antibody FC-2.15 on human polymorphonuclear neutrophils and MCF-7 breast tumor cells. In vitro and ex vivo studies
    Mariana Capurro
    Cecilia Ballaré
    Laura Bover
    Paula Portela
    Jesé Mordoh
    Cancer Immunology, Immunotherapy, 1999, 48 : 100 - 108
  • [48] Differential lytic and agglutinating activity of the anti-LewisX monoclonal antibody FC-2.15 on human polymorphonuclear neutrophils and MCF-7 breast tumor cells.: In vitro and ex vivo studies
    Capurro, M
    Ballaré, C
    Bover, L
    Portela, P
    Mordoh, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (2-3) : 100 - 108